Renew Biotechnologies

Tomorrow kicks off the BioUtah Entrepreneur & Investor Life Sciences Summit 2025! Renew Biotechnologies is proud to be a part of this event. Our CEO, Chad Pollard, will share "Real Life Experiences from Startup CEOs in the Trenches" on a panel with other industry leaders and innovators. To learn more, visit: https://www.renewbt.com/? To register for the event, visit: https://lnkd.in/gk9GBfj #LifeSciencesSummit #Biotech #Innovation #NextGenSequencing #Methylation #BioUtah?

Proud to see Resonant’s technology powering collaboration between Brigham Young University and University of Kansas Medical Center Alzheimer’s Disease Research Center, advancing early detection and monitoring of Alzheimer’s disease. #BiotechInnovation #Collaboration #AlzheimersDisease #Neurodegeneration #CellFreeDNA #EndAlz?

Honored to receive the BioTech Breakthrough Award for “DNA Sequencing Innovation of the Year.” This award highlights our robust and evolving technology ecosystem, which serves as the foundation for innovation across Renew’s diverse portfolio, including neurodegenerative diseases, women’s health, pathogen detection, and more. Through Wasatch Biolabs, a Renew Biotechnologies subsidiary and high-throughput clinical laboratory, we are excited to also offer our sequencing applications for third-party use. This allows diagnostic companies, healthcare institutions, and other organizations to deliver groundbreaking tests that enhance patient care and outcomes. Explore the full list of 2024 Biotech Breakthrough Award winners here: https://lnkd.in/gYXC6PQ5 To read the full press release, visit: https://lnkd.in/gmtgHw2J #BiotechInvestment #Innovation #Diagnostics #RenewBiotechnologies #WasatchBiolabs #PrecisionHealthcare

Big milestone for Wasatch Biolabs! Looking forward to future breakthroughs in methylation research and clinical epigenomics. https://lnkd.in/ePyqZGf8 #Innovation #Methylation #Research #ClinicalEpigenomics

We are thrilled to announce that Renew Biotechnologies has been ranked #5 in UV50's list of 2024 Startups to Watch! Being recognized among the top startups is an incredible honor and a testament to our team’s dedication to innovation and excellence in biotechnology. We are so grateful for the support from our partners, clients, and community as we continue driving impactful solutions and advancing Utah’s biotech industry. Thank you to UV50 for this recognition! https://lnkd.in/ediFdXi3 #UV50 #StartupsToWatch #BiotechInnovation #RenewBiotechnologies #GrowthAndInnovation #ThankYou

Chad Pollard represented Wasatch Biolabs at Oxford Nanopore Technologies first annual Biopharma day where he shared about the novel products that WBL has created. Excited to see the growth of our companies!

We had a great time presenting at BioUtah's networking event last week! Our very own Tim Jenkins, Co-Founder and VP of R&D, delivered a great presentation on the novel technologies being developed at Renew and the unique business model that allows us to encourage the next generation of biotech leaders by promoting student-led IP development and commercialization. We're proud to work at such an exciting intersection between entrepreneurship and academics. A big thank you to BioUtah for hosting a great event and to everyone who joined us! #Biotech #BioUtah #RenewBiotechnologies #BYU

Renew Biotechnologies is proud to announce our new Chief Operations Officer, Steven Abbott! https://lnkd.in/gVy_D9tt

Honored to announce that our CEO and Co-Founder, Chad Pollard, has been selected as one of Utah Valley BusinessQ’s 40 under 40! Every year for the past 25 years, Utah Valley BusinessQ has selected 40 honorees under 40 to celebrate the work of young entrepreneurs contributing the vibrant culture and community of Utah. Chad’s leadership and vision has propelled Renew Biotechnologies to pioneer groundbreaking diagnostic technologies and build meaningful relationships between biotech, academia, and healthcare professionals to enhance patient care. Join us in congratulating Chad on this well-deserved recognition! We’re excited to witness his continued vision, innovation, and success. #40under40 #Innovation #Leadership #RenewBiotechnologies #Biotechnology

Thrilled to see Wasatch Biolabs connecting at the 2024 AACR Conference last week! WBL’s participation underscores their commitment to translational science and advancing oncology patient care. We look forward to the potential collaborations and research insights gained from the event! To stay up-to-date with WBL's technology, research, and collaborations, visit:?wasatchbiolabs.com#precisionmedicine #precisiononcology #personalizedhealthcare #cancer #dnasequencing #epigenetics